1Hoyert DL, Xu J. Deaths: preliminary data for 2011[J]. Natl Vital St,at Rep, 2012, 61(6): 1-51.
2Lubel JS, Herath CB, BurreU LM, et al. Liver disease and the renin- angiotensin system: recent discoveries and clinical implications[J]. J Gastroenterol Hepatol, 2008, 23(9): 1327-1338.
3Bataller R, Gibele E, Parsons C J, et al. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats[J]. Hepatology, 2005, 41(5): 1046-1055.
4Vukelic S, Griendling KK. Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift[J]. Circ Res, 2014, 114(5): 754-757.
5Montezano AC, Nguyen Dinh Cat A, Rios F J, et al. Angiotensin II and vascular injury[J]. Curr Hypertens Rep, 2014, 16(6): 431.
6Kim G, Kim J, Lim YL, et al. Renin-angiotensin system inhibitors and fibrosis in chronic liver disease: a systematic review[J]. Hepatol Int, 2016, 10(5): 819-828.
7Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers[J]. Gastroenterology, 2003, 124(1): 91-96.
8Helmy A, Jalan R, Newby DE, et al. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis[J]. Gastroenterology, 2000, 1 18(3): 565-572.
9Grace JA, Herath CB, Mak KY, et al. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options[J]. Clin Sci (Lond), 2012, 123(4): 225-239.
10Debernardi-Venon W, Martini S, Biasi F, et al. AT1 receptor antagonist candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers[J]. J Hepatol, 2007, 46(6): 1026- 1033.
2Luca A,Angermayr B,Bertolini G,et al.An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis.Liver Transpl,2007,13:1174-1180.
3Huo TI,Lin HC,Huo SC,et al.Comparison of four model for endstage liver disease-based prognostic systems for cirrhosis.Liver Transpl,2008,14:837-844.
4Wong VW,Chim AM,Wong GL,et al.Performance of the new MELD-Na score in predicting 3-month and 1-year mortality in Chinese patients with chronic hepatitis B.Liver Transpl,2007,13:1228-1235.
5Pataro,Carla;Santos,Alessandra;Correa,SprayaR.,Physiological characterization of yeasts isolated from artisanal fermentation in an Aguardente distillery[J].Rev. Microbiol, 1998,29(2): 104-108.
6Gunter Wolf,Fuad N. Ziyadeh,Rolf A.K. Stahl. [J] 1999,Journal of Molecular Medicine(7):556～564
